Northern Trust
CLYM

Northern Trust’s Climb Bio CLYM Stock Holding History

Northern Trust’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31M Buy
330,290
+202,386
+158% +$2.09M ﹤0.01% 2702
2026
Q1 		$876K Buy
127,904
+3,234
+3% +$18.7K ﹤0.01% 3402
2025
Q4 		$499K Sell
124,670
-753
-0.6% -$1.81K ﹤0.01% 3656
2025
Q3 		$252K Sell
125,423
-16,001
-11% -$29.7K ﹤0.01% 3900
2025
Q2 		$175K Sell
141,424
-159,462
-53% -$198K ﹤0.01% 3978
2025
Q1 		$367K Sell
300,886
-12,952
-4% -$21K ﹤0.01% 3701
2024
Q4 		$565K Buy
313,838
+21,227
+7% +$76.8K ﹤0.01% 3614
2024
Q3 		$1.49M Buy
292,611
+246,934
+541% +$1.75M ﹤0.01% 3165
2024
Q2 		$325K Buy
45,677
+2,209
+5% +$14.7K ﹤0.01% 3665
2024
Q1 		$119K Sell
43,468
-5,244
-11% -$14.4K ﹤0.01% 4030
2023
Q4 		$132K Buy
48,712
+37,530
+336% +$97.6K ﹤0.01% 4042
2023
Q3 		$29.4K Hold
11,182
– – ﹤0.01% 4265
2023
Q2 		$31.3K Sell
11,182
-65
-0.6% -$197 ﹤0.01% 4322
2023
Q1 		$32.6K Sell
11,247
-247
-2% -$848 ﹤0.01% 4361
2022
Q4 		$42.2K Hold
11,494
– – ﹤0.01% 4321
2022
Q3 		$37K Hold
11,494
– – ﹤0.01% 4407
2022
Q2 		$35K Sell
11,494
-44,087
-79% -$209K ﹤0.01% 4515
2022
Q1 		$466K Sell
55,581
-5,714
-9% -$53.3K ﹤0.01% 3767
2021
Q4 		$641K Sell
61,295
-741
-1% -$11K ﹤0.01% 3722
2021
Q3 		$1.12M Buy
+62,036
New +$1.28M ﹤0.01% 3516

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's CLYM Position: Q2 2026 in Review

Northern Trust increased its Climb Bio (CLYM) stake by 158% in Q2 2026, buying an estimated $2.09M and bringing the position to 330,290 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

Northern Trust first reported a position in CLYM in Q3 2021 and has held it in 20 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Northern Trust held 330,290 shares of Climb Bio worth $4.31M as of Q2 2026.
  • Northern Trust bought 202,386 Climb Bio shares in Q2 2026, an estimated $2.09M.
  • Climb Bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2702 holding.
  • Northern Trust first reported a position in Climb Bio in Q3 2021 and has held it in 20 quarters since.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.